Used in pharmaceutical research as a potent inhibitor of tyrosine kinases, particularly in the development of anticancer agents. It shows promise in targeting signaling pathways involved in tumor growth and proliferation. Its structure allows for strong binding to kinase domains, enhancing its efficacy in cell-based assays. Investigated for use in treating solid tumors and hematological malignancies due to its ability to induce apoptosis and inhibit cell migration. Also employed as a lead compound in structure-activity relationship (SAR) studies to optimize drug-like properties in kinase inhibitor development.